Bullish Case: COMP at $9.395 shows mean reversion with density mass near $9-10. Helium's term structure (78% Nov falling to ~51-53% Feb-May) sits well below market IV (87% Nov, 66-68% back), implying near-term event premium is overpriced and theta favors premium sellers. The +2.64% Helium forecast, positive agent-attrition-driven margin story, and Anywhere synergy execution support a grind toward $10-11.

Bearish Case: Put volume runs 35% above calls, price is -11% over 60 days and -3.6% on the week, and Nov IV at 87% (Helium's front-node up to 96%) prices real downside tail risk. High rates keep mortgage demand depressed, agent attrition may cut revenue faster than OpEx savings, and thin option liquidity amplifies gap moves below $9. Backwardated front structure signals stress is priced for a reason.

Potential Outcomes:

1. 40% Range $8.8-10.0 through Q1: mean-reversion density + flattening Helium curve; falsified if Nov ATM IV stays >80% while spot <9.
2. 20% Recovery $10.5-12: Q4 earnings beat, IV compresses below 60% front.
3. 22% Slide to $7.5-8.5: housing macro deterioration, front IV >95%.
4. 12% Vol spike, spot ±5%: IV term inverts with flat price.
5. 6% Tail gap >20%: idiosyncratic shock; deep-OTM put skew (IV 200-400%) flags this.

October 30, 2026